NCT03687593View on ClinicalTrials.gov

Safety and Performance Using Legion™ CR Oxinium and CoCr Femoral Implants Combined With Legion™/Genesis™ II XLPE High Flex Tibial Inserts

Active, not recruitingOBSERVATIONAL
Enrollment

126

Participants

Timeline

Start Date

August 26, 2018

Primary Completion Date

October 1, 2027

Study Completion Date

April 1, 2028

Conditions
Total Knee Arthroplasty
Interventions
DEVICE

Legion™ CR Oxinium and CoCr Femoral Implants combined with Legion™/Genesis™ II XLPE High Flex Tibial Inserts

Single arm study, all subjects received the Legion™ CR Femoral Oxinium and CoCr Implant with Legion™/Genesis™ II XLPE Hi-flex Tibial Insert

Trial Locations (4)

29615

Hawkins Foundation, Greenville

37604

Appalachian Orthopedic Associates, Johnson City

55439

Allina Health Systems, Edina

89503

ROC Foundation, Reno

All Listed Sponsors
lead

Smith & Nephew, Inc.

INDUSTRY

NCT03687593 - Safety and Performance Using Legion™ CR Oxinium and CoCr Femoral Implants Combined With Legion™/Genesis™ II XLPE High Flex Tibial Inserts | Biotech Hunter | Biotech Hunter